Ruby QC Investment exits Akums Drugs

SENSEX   85,567.48

+ 638.12

NIFTY   26,172.40

+ 206.00

CRUDEOIL   5,215.00

+ 110.00

GOLD   136,258.00

+ 2,062.00

SILVER   213,182.00

+ 4,743.00

Ruby QC Investment Holdings Pte sold its entire holding of 72.78 lakh shares (or 4.62 per cent of paid-up equity) in Akums Drugs & Pharmaceuticals for ₹311.5 crore, to ICICI Prudential Mutual Fund. According to bulk deal data with NSE, the shares were sold at an average price of ₹428. ICICI Prudential acquired the entire stake. The stock on Monday closed 3.8 per cent higher at ₹443.70 on the BSE. Ruby QC Investment is associated with Quadria Capital.

Akums Drugs hit the capital market last year in August 2024 at a price band of ₹646-679. After hitting a high of ₹1,066.65 immediately after the listing, the stock has been on a secular downtrend.

Published on December 22, 2025

THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.

THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.